Chinese medicine prescription for treating hyperuricemia

Abstract

The invention discloses a Chinese traditional prescription for treating hyperuricemia. The medicine contains Smilax Glbra Roxb, Rhizoma Dioscoreae Seplemlobae, Bulbus Iphigeniae Indicae, Semen Vaccariae and Radix Achyranthis Bidentatae. The weight proportions of the five drugs are Smilax Glbra Roxb 3.5-4.5 part, Rhizoma Dioscoreae Seplemlobae 1.5-2.0 parts, Bulbus Iphigeniae Indicae 1.2-1.8 parts, Semen Vaccariae 1-1.5 parts and Radix Achyranthis Bidentatae 1-1.5 parts. The Chinese traditional medicine formulation is the traditional decoction pieces water decoction, capsules or granules. The invention has the advantages that firstly, after restrict theoretical reasoning and a great number of tests and selections, the five drugs are selected and can achieve the efficacies of the original twenty drugs, thereby the prescription is simplified to the utmost extent, the quality problem in the production process can be more effectively controlled and the prescription is more facilitated in further development and study as the pure Chinese traditional medicine preparation; secondly, the medicine can be prepared into various formula, fulfilling different needs of different patients.

Description

technical field

[0001] The invention relates to a traditional Chinese medicine, in particular to a traditional Chinese medicine for treating hyperuricemia. Background technique

[0002] With the improvement of people's living standards in our country and the change of dietary structure, the incidence of hyperuricemia has increased significantly in recent years. Hyperuricemia can lead to gout, uric acid nephropathy, and renal insufficiency, and is related to hypertension, hyperlipidemia, coronary heart disease, stroke, and diabetes. The prevention and treatment of hyperuricemia is gradually receiving attention. Hyperuricemia is a group of diseases caused by purine metabolism disorder or uric acid excretion disorder. It is an important biochemical basis of gout, kidney stones and other diseases. Clinically, asymptomatic hyperuricemia is very common and potentially dangerous. Although there are drugs that inhibit uric acid production and promote excretion, such as allopurinol...

Examples

Embodiment 1

[0014] During the study, symptoms, changes in signs, and adverse drug reactions will be observed in detail. Blood and urine routine tests and blood uric acid tests will be done before medication, 10 days after medication, and the day after the end of the course of treatment; liver and kidney functions will be checked before medication and the day after the end of the course of treatment. .

[0015] The curative effect evaluation standard is divided into three grades: markedly effective, effective and ineffective. Markedly effective refers to the obvious decrease of blood uric acid within 10 days of treatment (male ≤ 350umol / L, female ≤ 300umol / L), and it is stable in this range during treatment; effective means that the blood uric acid level drops to normal after treatment, and male > 350umol / L L, female > 300umol / L, or blood uric acid did not drop to normal after treatment, but decreased by ≥ 20% compared with before treatment; ineffective refers to the blood uric acid level ...

Embodiment 2

[0021] During the study, symptoms, changes in signs, and adverse drug reactions will be observed in detail. Blood and urine routine tests and blood uric acid tests will be done before medication, 10 days after medication, and the day after the end of the course of treatment; liver and kidney functions will be checked before medication and the day after the end of the course of treatment. .

[0022] The curative effect evaluation standard is divided into three grades: markedly effective, effective and ineffective. Significantly effective means that blood uric acid drops significantly after 10 days of treatment (350umol / L for men, ≤300umol / L for women), and stabilizes within this range during treatment; effective means that the blood uric acid level drops to normal after treatment, and men> 350umol / L , women>300umol / L, or blood uric acid did not drop to normal after treatment, but decreased by ≥20% compared with before treatment; ineffective refers to the blood uric acid level d...

Embodiment 3

[0028] During the study, symptoms, changes in signs, and adverse drug reactions will be observed in detail. Blood and urine routine tests and blood uric acid tests will be done before medication, 10 days after medication, and the day after the end of the course of treatment; liver and kidney functions will be checked before medication and the day after the end of the course of treatment. .

[0029] The curative effect evaluation standard is divided into three grades: markedly effective, effective and ineffective. Markedly effective refers to the obvious decrease of blood uric acid within 10 days of treatment (male ≤ 350umol / L, female ≤ 300umol / L), and it is stable in this range during treatment; effective means that the blood uric acid level drops to normal after treatment, and male > 350umol / L L, female > 300umol / L, or blood uric acid did not drop to normal after treatment, but decreased by ≥ 20% compared with before treatment; ineffective refers to the blood uric acid level ...

technical field

[0001] The invention relates to a traditional Chinese medicine, in particular to a traditional Chinese medicine for treating hyperuricemia. Background technique

[0002] With the improvement of people's living standards in our country and the change of dietary structure, the incidence of hyperuricemia has increased significantly in recent years. Hyperuricemia can lead to gout, uric acid nephropathy, and renal insufficiency, and is related to hypertension, hyperlipidemia, coronary heart disease, stroke, and diabetes. The prevention and treatment of hyperuricemia is gradually receiving attention. Hyperuricemia is a group of diseases caused by purine metabolism disorder or uric acid excretion disorder. It is an important biochemical basis of gout, kidney stones and other diseases. Clinically, asymptomatic hyperuricemia is very common and potentially dangerous. Although there are drugs that inhibit uric acid production and promote excretion, such as allopurinol...

Examples

Embodiment 1

[0014] During the study, symptoms, changes in signs, and adverse drug reactions will be observed in detail. Blood and urine routine tests and blood uric acid tests will be done before medication, 10 days after medication, and the day after the end of the course of treatment; liver and kidney functions will be checked before medication and the day after the end of the course of treatment. .

[0015] The curative effect evaluation standard is divided into three grades: markedly effective, effective and ineffective. Markedly effective refers to the obvious decrease of blood uric acid within 10 days of treatment (male ≤ 350umol / L, female ≤ 300umol / L), and it is stable in this range during treatment; effective means that the blood uric acid level drops to normal after treatment, and male > 350umol / L L, female > 300umol / L, or blood uric acid did not drop to normal after treatment, but decreased by ≥ 20% compared with before treatment; ineffective refers to the blood uric acid level ...

Embodiment 2

[0021] During the study, symptoms, changes in signs, and adverse drug reactions will be observed in detail. Blood and urine routine tests and blood uric acid tests will be done before medication, 10 days after medication, and the day after the end of the course of treatment; liver and kidney functions will be checked before medication and the day after the end of the course of treatment. .

[0022] The curative effect evaluation standard is divided into three grades: markedly effective, effective and ineffective. Significantly effective means that blood uric acid drops significantly after 10 days of treatment (350umol / L for men, ≤300umol / L for women), and stabilizes within this range during treatment; effective means that the blood uric acid level drops to normal after treatment, and men> 350umol / L , women>300umol / L, or blood uric acid did not drop to normal after treatment, but decreased by ≥20% compared with before treatment; ineffective refers to the blood uric acid level d...

Embodiment 3

[0028] During the study, symptoms, changes in signs, and adverse drug reactions will be observed in detail. Blood and urine routine tests and blood uric acid tests will be done before medication, 10 days after medication, and the day after the end of the course of treatment; liver and kidney functions will be checked before medication and the day after the end of the course of treatment. .

[0029] The curative effect evaluation standard is divided into three grades: markedly effective, effective and ineffective. Markedly effective refers to the obvious decrease of blood uric acid within 10 days of treatment (male ≤ 350umol / L, female ≤ 300umol / L), and it is stable in this range during treatment; effective means that the blood uric acid level drops to normal after treatment, and male > 350umol / L L, female > 300umol / L, or blood uric acid did not drop to normal after treatment, but decreased by ≥ 20% compared with before treatment; ineffective refers to the blood uric acid level ...